Targeting Telomerase Enhances Cytotoxicity of Salinomycin in Cancer Cells
Sign Up to like & getrecommendations! Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.2c04082
Abstract: Salinomycin exhibits significant systemic adverse reactions such as tachycardia and myoglobinuria in mammals, which hinders its application as a drug for human cancers. Although many strategies aimed at increasing salinomycin’s toxicity to cancer cells have… read more here.
Keywords: cancer; cytotoxicity; salinomycin; targeting telomerase ... See more keywords